124 related articles for article (PubMed ID: 36697348)
1. Metanalyses on metformin's role in pancreatic cancer suffer from severe bias and low data quality - An umbrella review.
Nowicka Z; Matyjek A; Płoszka K; Łaszczych M; Fendler W
Pancreatology; 2023 Mar; 23(2):192-200. PubMed ID: 36697348
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Metformin and pancreatic cancer survival: Real effect or immortal time bias?
Wei M; Liu Y; Bi Y; Zhang ZJ
Int J Cancer; 2019 Oct; 145(7):1822-1828. PubMed ID: 30848544
[TBL] [Abstract][Full Text] [Related]
4. Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis.
Jian-Yu E ; Graber JM; Lu SE; Lin Y; Lu-Yao G; Tan XL
Curr Med Chem; 2018; 25(22):2595-2607. PubMed ID: 28403788
[TBL] [Abstract][Full Text] [Related]
5. The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis.
Li X; Li T; Liu Z; Gou S; Wang C
Sci Rep; 2017 Jul; 7(1):5825. PubMed ID: 28724893
[TBL] [Abstract][Full Text] [Related]
6. Impact of Metformin on Cancer Biomarkers in Non-Diabetic Cancer Patients: A Systematic Review and Meta-Analysis of Clinical Trials.
Farkhondeh T; Amirabadizadeh A; Aramjoo H; Llorens S; Roshanravan B; Saeedi F; Talebi M; Shakibaei M; Samarghandian S
Curr Oncol; 2021 Apr; 28(2):1412-1423. PubMed ID: 33917520
[TBL] [Abstract][Full Text] [Related]
7. Metformin and health outcomes: An umbrella review of systematic reviews with meta-analyses.
Li X; Celotto S; Pizzol D; Gasevic D; Ji MM; Barnini T; Solmi M; Stubbs B; Smith L; López Sánchez GF; Pesolillo G; Yu Z; Tzoulaki I; Theodoratou E; Ioannidis JPA; Veronese N; Demurtas J
Eur J Clin Invest; 2021 Jul; 51(7):e13536. PubMed ID: 33709434
[TBL] [Abstract][Full Text] [Related]
8. Immortal time bias exaggerates the effect of metformin on the risk of gastric cancer: A meta-analysis.
Wang YB; Tan LM; Luo L; Yan S; Huang Q; Wang Y; Deng T; Shi Y; Deng Y; Jin YH
Pharmacol Res; 2021 Mar; 165():105425. PubMed ID: 33453371
[TBL] [Abstract][Full Text] [Related]
9. Metformin and prostate cancer mortality: a meta-analysis.
Stopsack KH; Ziehr DR; Rider JR; Giovannucci EL
Cancer Causes Control; 2016 Jan; 27(1):105-13. PubMed ID: 26537119
[TBL] [Abstract][Full Text] [Related]
10. Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea.
Jang WI; Kim MS; Kang SH; Jo AJ; Kim YJ; Tchoe HJ; Park CM; Kim HJ; Choi JA; Choi HJ; Paik EK; Seo YS; Yoo HJ; Kang JK; Han CJ; Kim YJ; Kim SB; Ko MJ
Oncotarget; 2017 Feb; 8(6):9587-9596. PubMed ID: 28077783
[TBL] [Abstract][Full Text] [Related]
11. The Potential Effect of Metformin on Cancer: An Umbrella Review.
Yu H; Zhong X; Gao P; Shi J; Wu Z; Guo Z; Wang Z; Song Y
Front Endocrinol (Lausanne); 2019; 10():617. PubMed ID: 31620081
[No Abstract] [Full Text] [Related]
12. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
Wang Z; Lai ST; Xie L; Zhao JD; Ma NY; Zhu J; Ren ZG; Jiang GL
Diabetes Res Clin Pract; 2014 Oct; 106(1):19-26. PubMed ID: 24837144
[TBL] [Abstract][Full Text] [Related]
13. Metformin use is not associated with colorectal cancer incidence in type-2 diabetes patients: evidence from methods that avoid immortal time bias.
Zhang HS; Yang Y; Lee S; Park S; Nam CM; Jee SH
Int J Colorectal Dis; 2022 Aug; 37(8):1827-1834. PubMed ID: 35831458
[TBL] [Abstract][Full Text] [Related]
14. Metformin's Modulatory Effects on miRNAs Function in Cancer Stem Cells-A Systematic Review.
Malinowski B; Musiała N; Wiciński M
Cells; 2020 Jun; 9(6):. PubMed ID: 32512882
[TBL] [Abstract][Full Text] [Related]
15. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
16. Metformin Associated With Increased Survival in Type 2 Diabetes Patients With Pancreatic Cancer and Lymphoma.
Wynn A; Vacheron A; Zuber J; Solomon SS
Am J Med Sci; 2019 Sep; 358(3):200-203. PubMed ID: 31324361
[TBL] [Abstract][Full Text] [Related]
17. Effects of metformin on survival outcomes of pancreatic cancer patients with diabetes: A meta-analysis.
Xin W; Fang L; Fang Q; Zheng X; Huang P
Mol Clin Oncol; 2018 Mar; 8(3):483-488. PubMed ID: 29468063
[TBL] [Abstract][Full Text] [Related]
18. An observational study to justify and plan a future phase III randomized controlled trial of metformin in improving overall survival in patients with inoperable pancreatic cancer without liver metastases.
Broadhurst PJ; Hart AR
J Cancer Res Clin Oncol; 2020 May; 146(5):1369-1375. PubMed ID: 32157435
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Metformin on Vestibular Schwannoma Growth: A Systematic Review and Meta-analysis.
Lovin BD; Wilkinson AJ; Qing Y; Hernandez M; Nader ME; Raza S; DeMonte F; Gidley PW
Laryngoscope; 2023 Sep; 133(9):2066-2072. PubMed ID: 36744870
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
